Hiscox Limited

Director's Dealing • Aug 7, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2842I

Hiscox Ltd

07 August 2019

Hiscox Ltd

(the 'Company')

Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMR')

Hamilton, Bermuda - The Company has been notified that Mr Richard Watson, Executive Director, has sold 10,000 Ordinary Shares of 6.5p each in the Company on 6 August 2019, at a price of £15.8471 per Share.

The above transactions were executed in GBP.

The notification as required by the EU Market Abuse Regulation (EU 596/2014) is set out below.  

Marc Wetherhill

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Watson

2

Reason for the notification

a)

Position/status

PDMR - Chief Underwriting Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hiscox Ltd

b)

LEI

5493007JXOLJ0QCY2D70

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 6.5p each

ISIN: BMG4593F1389

b)

Nature of the transaction

Share sale

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£15.8471	10,000

d)

Aggregated information

- Aggregated volume

- Price

Aggregated Volume	Aggregated Price
10,000	£158,471.00

e)

Date of the transaction

2019-08-06

f)

Place of the transaction

LONDON STOCK EXCHANGE, XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBDGDIIBGBGCR